Top compounds associated with response to ERCC5


Feature Type Standardized
Nominal ANOVA
mRNA LY317615 GDSC1000 pan-cancer AAC 0.088 0.02
mRNA BRD-K30748066 CTRPv2 pan-cancer AAC 0.28 0.02
mRNA decitabine CTRPv2 pan-cancer AAC 0.067 0.02
mRNA Gefitinib GDSC1000 pan-cancer AAC 0.081 0.02
mRNA Rapamycin gCSI pan-cancer AAC -0.13 0.03
mRNA BMS-536924 GDSC1000 pan-cancer AAC 0.078 0.03
mRNA AZD7762 CTRPv2 pan-cancer AAC 0.077 0.03
mRNA S-Trityl-L-cysteine GDSC1000 pan-cancer AAC 0.12 0.03
mRNA selumetinib:navitoclax (8:1 mol/mol) CTRPv2 pan-cancer AAC 0.085 0.03
mRNA selumetinib:tretinoin (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.082 0.03
Download CSV